Pacritinib protects dendritic cells more efficiently than ruxolitinib.
Experimental hematology
View this publicationExperimental hematology
View this publicationCancer immunology, immunotherapy : CII
View this publicationMolecular cancer
View this publicationBMC biology
View this publicationRadiology. Cardiothoracic imaging
View this publicationJournal of cancer research and clinical oncology
View this publicationMolecular cancer
View this publicationAnnals of hematology
View this publicationCirculation. Cardiovascular imaging
View this publicationNature immunology
View this publication